Aptevo Therapeutics GAAP EPS of -$2.23 misses by $0.14

* Aptevo Therapeutics press release [https://seekingalpha.com/pr/20296735-aptevo-therapeutics-reports-3q25-financial-results-and-provides-a-business-update] (APVO [https://seekingalpha.com/symbol/APVO]): Q3 GAAP EPS of -$2.23 misses by $0.14.
* Reported a net loss of $7.5M in Q3 2025 against a net loss of $5.1M in Q3 2024.

MORE ON APTEVO THERAPEUTICS

* Seeking Alpha’s Quant Rating on Aptevo Therapeutics [https://seekingalpha.com/symbol/APVO/ratings/quant-ratings]
* Historical earnings data for Aptevo Therapeutics [https://seekingalpha.com/symbol/APVO/earnings]
* Financial information for Aptevo Therapeutics [https://seekingalpha.com/symbol/APVO/income-statement]